To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.
Find out MoreDate | Source | Headline | |
---|---|---|---|
13th Nov 2017 | 4:30 pm | RNS | Holding(s) in Company |
20th Oct 2017 | 5:00 pm | RNS | Holding(s) in Company |
20th Oct 2017 | 4:00 pm | RNS | Net Asset Value(s) |
21st Sep 2017 | 10:03 am | RNS | Net Asset Value(s) |
21st Sep 2017 | 7:00 am | RNS | Half-year Report |
24th Aug 2017 | 3:15 pm | RNS | Notice of Results |
22nd Aug 2017 | 3:22 pm | RNS | Notice of Results |
21st Aug 2017 | 4:00 pm | RNS | Net Asset Value(s) |
21st Jul 2017 | 4:00 pm | RNS | Net Asset Value(s) |
30th Jun 2017 | 4:30 pm | RNS | Reduction of share premium account |
19th Jun 2017 | 4:00 pm | RNS | Net Asset Value(s) |
22nd May 2017 | 4:00 pm | RNS | Net Asset Value(s) |
3rd May 2017 | 2:05 pm | RNS | Correction: Final Results of Issue |
25th Apr 2017 | 4:14 pm | RNS | Net Asset Value(s) |
12th Apr 2017 | 11:24 am | RNS | Holding(s) in Company |
6th Apr 2017 | 6:00 pm | RNS | Correction: Total Voting Rights |
6th Apr 2017 | 3:45 pm | RNS | Holding(s) in Company |
6th Apr 2017 | 3:45 pm | RNS | Holding(s) in Company |
5th Apr 2017 | 5:30 pm | RNS | Holding(s) in Company |
5th Apr 2017 | 4:30 pm | RNS | Holding(s) in Company |
3rd Apr 2017 | 3:00 pm | RNS | Total Voting Rights |
31st Mar 2017 | 6:00 pm | RNS | Holding(s) in Company |
31st Mar 2017 | 2:15 pm | RNS | Director/PDMR Shareholding |
31st Mar 2017 | 1:45 pm | RNS | Total Voting Rights |
30th Mar 2017 | 1:00 pm | RNS | Director/PDMR Shareholding |
29th Mar 2017 | 11:00 am | RNS | Holding(s) in Company |
29th Mar 2017 | 10:30 am | RNS | Director/PDMR Shareholding |
28th Mar 2017 | 10:30 am | RNS | Director/PDMR Shareholding |
28th Mar 2017 | 10:30 am | RNS | Director/PDMR Shareholding |
28th Mar 2017 | 10:30 am | RNS | Director/PDMR Shareholding |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.